DCVC (Data Collective) β 2021 Investments
8 investments dated 2021 Β· listed companies and verified rows first Β· show all
Waltham, US
Anil Chitkara(Executive Officer)Michael Ellenbogen(Executive Officer, Director)Kevin O'Brien(Executive Officer)
BoardJoel Cutler(Director)Patrick Ennis(Director)Bilal Zuberi(Director)in
Board seatMerline SaintilAlan CohenΒ· per SEC Form D Β· $30M raise Β· filed Feb 2021
Co-investorsOUP (Osage University Partners)Lux Capital
Amplitude provides an AI analytics platform that helps companies understand customer behavior and make data-driven product decisions.
Data & InfrastructureDeveloper ToolsEnterprise SoftwareMarketing TechSaaSSan Francisco, US
Spenser Skates(Founder/CEO)inCurtis Liu(Founder/CTO)inJeffrey Wang(Co-founder)inAndrew Casey(Chief Financial Officer)Nathaniel Crook(Chief Commercial Officer)
Co-investorsBattery VenturesSequoia Capital91 VenturesBoxGroupFelicis VenturesFika+14 more
Valar Labs develops AI-powered pathology analysis tools to assist physicians in cancer treatment decisions.
AI & Machine LearningHealthtechMedical DevicesPalo Alto, US
Anirudh Joshi(Co-founder & CEO)inViswesh Krishna(Co-founder & CTO)Damir Vrabac(Executive Officer, Director)in
Co-investorsAndreessen HorowitzMartin VenturesREMUS CapitalPear VC
Axelar is a blockchain interoperability network that connects institutions to onchain ecosystems through a single integration, letting them deploy stablecoins, real-world assets, and funds across 80+ blockchains.
Crypto & Web3Data & InfrastructureFintechWaterloo
Sergey Gorbunov(Executive Officer, Director)Georgios Vlachos(Director)
Co-investorsAndromeda CapitalBitDAOCoinbase VenturesCollab+CurrencyDivergenceDragonfly+11 more
Metabiota Health provides personalized nutrition guidance, lifestyle recommendations, and dietary supplement advice based on scientific research.
ConsumerDigital HealthWellness & FitnessMenlo Park, US
Nathan D. Wolfe(Executive Officer, Director)Michael Kertesz(Executive Officer, Director)
Co-investorsIn-Q-TelWP Global Partners
Frontier Medicines is a drug discovery company that combines chemoproteomics and AI to develop covalent small-molecule therapeutics against difficult-to-drug protein targets.
AI & Machine LearningBiotechDeep TechSouth San Francisco, US
Chris Varma, Ph.D.(Executive Officer, Director)Chris Varma(Co-founder, Chairman and CEO)Jim Winkler(Executive Officer)Johannes Hermann, Ph.D.(Executive Officer)Kevin Webster(Executive Officer)Gregory Chow(Executive Officer)
Co-investorsBerkeley CatalystDroia VenturesMPM BioImpactRA CapitalDCVC BioDeerfield Management Company
Persephone Biosciences develops a synbiotic (probiotic and prebiotic combination) supplement for infants designed to replenish key beneficial gut bacteria.
BiotechFemTechHealthtechSan Diego, US
Stephanie Culler(Founder/CEO)inStephen Van Dien(Founder/CTO)in
Co-investorsBioBritFifty YearsFirst Bight VenturesHemi Ventures, LlcOcampo CapitalY Combinator+1 more
Umoja Biopharma develops in vivo CAR T cell therapies, aiming to deliver this cancer treatment approach to a broader range of patients.
BiotechDigital HealthHealthtechMedical DevicesSeattle, US
Andrew M. Scharenberg(Executive Officer, Director)Philip S. Low(Director)
BoardIrena Melnikova(Executive Officer)Anna French(Director)Robert Glassman(Director)John Hamer(Director)in
Co-investorsMPM BioImpactDCVC BioQiming Venture Partners USASoftBank GroupK2 HealthVenturesSoftBank Vision Fund
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.